
The 54th International Symposium on High Performance Liquid Phase Separations and Related Techniques (HPLC 2025) will be held from Sunday through Thursday, June 15-19, 2025, in Bruges, Belgium.

The 54th International Symposium on High Performance Liquid Phase Separations and Related Techniques (HPLC 2025) will be held from Sunday through Thursday, June 15-19, 2025, in Bruges, Belgium.

LCGC International spoke with various corporate personalities about trends and developments in sample preparation.

The pivotal role of analytical chemistry in the medico-legal and forensic applications is explored in this article.

The method of standard additions (MoSA) enables quantification of volatile impurities in condensed-phase samples, such as emulsions, for which matrix-matched calibration standards are required. The technique is, however, expensive because it requires multiple analyses of each sample.

This article will discuss an ion-pair reversed-phase liquid chromatography mass spectrometry (IP-RPLC–MS) workflow for the characterization of three messenger RNA (mRNA) key critical quality attributes: 5’ Cap, ORF, and poly(A) tail.

The RIC group has evolved from its humble origins in a garage to a new state-of-the-art research site. LCGC International spoke to Koen Sandra, CEO of RIC group, at the official opening of the new site.

Saer Samanipour from the Van ‘t Hoff Institute for Molecular Sciences (HIMS) at the University of Amsterdam spoke to LCGC International about the benefits of a data-driven reversed-phase liquid chromatography (RPLC) approach his team developed.

Click here to download the Europe PDF of The Column November 2024 issue.

Click here to download the North America PDF of The Column November 2024 issue.

Politecnico di Milano scientists recently created a new optimization strategy for chromatographically purifying oligonucleotides.

Researchers from Bristol Myers Squibb and Sanofi recently tested a new means of using hydrophobic interaction chromatography (HIC) for removing impurities in monoclonal antibodies (mAbs).